Previously, UNC5D was found to be a tumor suppressor and frequently downregulated in primary renal cell carcinomas [18], neuroblastoma [28, 29], bladder cancer [30] and papillary thyroid cancer [31]. Here, UNC5D is linked to thyroid gland papillary carcinoma.